DAVID GRAHAM to Esophagitis, Peptic
This is a "connection" page, showing publications DAVID GRAHAM has written about Esophagitis, Peptic.
Connection Strength
0.489
-
An objective end point for dilation improves outcome of peptic esophageal strictures: a prospective randomized trial. Gastrointest Endosc. 1997 May; 45(5):354-9.
Score: 0.139
-
Prospective randomized comparison of polyvinyl bougies and through-the-scope balloons for dilation of peptic strictures of the esophagus. Gastrointest Endosc. 1995 Mar; 41(3):189-95.
Score: 0.120
-
Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005 Jun; 100(6):1243-50.
Score: 0.061
-
Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis. Dig Dis Sci. 1983 Jun; 28(6):559-63.
Score: 0.053
-
Why do apparently healthy people use antacid tablets? Am J Gastroenterol. 1983 May; 78(5):257-60.
Score: 0.053
-
H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter. 1998 Sep; 3(3):145-51.
Score: 0.038
-
Esophageal motor abnormality during hiccup. Gastroenterology. 1986 Jun; 90(6):2039.
Score: 0.016
-
Bougienage is effective therapy for most benign esophageal strictures. JAMA. 1978 Sep 01; 240(9):844-7.
Score: 0.010